scholarly journals Percutaneous antegrade nephroscopic holmium laser pyelotomy: Novel endourologic technique for removal of extruded ureteral stent

2013 ◽  
Vol 7 (11-12) ◽  
pp. 830
Author(s):  
Jonathan Rhee ◽  
Stephen S Steele ◽  
Darren Beiko

Ureteral stent malposition outside of the urinary tract is a very uncommon complication of retrograde or antegrade ureteral stent insertion. There are few reports of open, laparoscopic or endourologic approaches to remove malpositioned stents. We present a novel technique for the removal of an extruded retroperitoneal ureteral stent using percutaneous antegrade nephroscopic holmium laser pyelotomy. This previously undescribed procedure represents a new soft tissue application of the holmium laser.

2020 ◽  
Vol 39 (11) ◽  
pp. 2077-2083 ◽  
Author(s):  
Bérénice Souhail ◽  
Patrick Charlot ◽  
Gilles Deroudilhe ◽  
Yves Coblentz ◽  
Gregory Pierquet ◽  
...  

2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
Ciciu Elena ◽  
Ana-Maria Pașatu-Cornea ◽  
Liliana-Ana Tuta

Abstract Background and Aims Ureterohydronephrosis (UHN) is a common anatomical change during the evolution of pregnancy, especially after 20th week of pregnancy. Factors responsible for dilation of pyelocaliceal system are hormonal changes, progressive obstruction and modification of the route of uterine and iliac vessels in the pelvic area. The main symptom of UHN is lumbar pain which is controlled in most of the cases by conservatory treatment.The aim of study was to o evaluate the stages of UHN during pregnancy depending on gestational age and to highlight the involvement of the pregnant uterus, as well as monitor the symptomatology and adequate management of these anatomical and physiological changes, that can associate variable complications, with maternal-fetal risk, during pregnancy. Method We performed a descriptive, transversal study for examination of pregnant women with symptomatic hydronephrosis. A total number of 104 patients, hospitalized in the Obstetrics and Gynecology Department of the Constanta County Emergency Hospital, were included, with nephrological monitoring using biological and imagistic examination for each pregnancy. Results The frequency of UHN in our study was 58% (60 cases) from the total number of 104 pregnant women. Regarding the gestational age, UHN was most commonly seen in the third trimester in 44 cases, followed by second trimester with 14 cases and first semester with only 2 cases. The right UHN was seen in all cases and the left UHN was seen in only 68 % of the cases. Our data showed that grade III of UHN reached a peak between 28 and 31 weeks of pregnancy and occurred in 37 (49%) pregnant women. Analyzing the parity, it was observed that 56% of the primiparous women developed UHN and 59% of the multiparous patients, showing us that the association with parity is not statistically significant. The majority of our patients (96.66%) were symptomatic, and the most common accuse on presentation was the lumbar pain. According to the visual analog scale (VAS) of the lumbar pain, the group could be distributed as follows: 17% with severe pain, 37 % with moderate pain and 13 % with mild pain. Eight pregnant women (13.33%) from our study developed UHN due to passage of ureteral stone, although, the majority got complicated with urinary tract infection (asymptomatic bacteriuria, acute cystitis, acute pyelonephritis) and even acute kidney injury (4 cases- 6,66%).97% of the symptomatic UHN responded to antispastic and analgesic therapy, antibiotics and adequate hydration. From our study group, only 2 patients (3,33%) with severe symptomatic UHN needed ureteral stent insertion, because initially they did not respond to medical, conservative treatment. Conclusion Uretrohydronephrosis is a common anatomical change in pregnancy and is depending on the gestational age. Parity did not influence the development of hydronephrosis in our study group. The most common symptom of ureterohydronephrosis during pregnancy is the lumbar pain, which can have different types of intensity (usually moderate to severe). Conservatory treatment during symptomatic, complicated ureterohydronephrosis is efficient in most cases, otherwise urological interventions with ureteral stent insertion must be initiated, because are effective and safe.


2002 ◽  
Vol 167 (3) ◽  
pp. 1334-1337 ◽  
Author(s):  
ELIJAH O. KEHINDE ◽  
VINCENT O. ROTIMI ◽  
KHALEEL A. AL-AWADI ◽  
HAMDY ABDUL-HALIM ◽  
FAREEDA BOLAND ◽  
...  

2002 ◽  
pp. 1334-1337 ◽  
Author(s):  
ELIJAH O. KEHINDE ◽  
VINCENT O. ROTIMI ◽  
KHALEEL A. AL-AWADI ◽  
HAMDY ABDUL-HALIM ◽  
FAREEDA BOLAND ◽  
...  

2020 ◽  
Vol 35 (Supplement_3) ◽  
Author(s):  
Melissa Rau ◽  
Anna Carrera Salinas ◽  
Sara Marti ◽  
Maria Fiol ◽  
Begoña Etcheverry ◽  
...  

Abstract Background and Aims Ureteral stent insertion is nowadays a common practice in kidney transplantation, leading to a dramatic reduction of surgical issues. On the other hands, urinary tract infections are the most common complication in the first months after transplant. Main scope of our study was to analyze the incidence of stent colonization and its impact on the development of urinary tract infection (UTI) in the first six months after transplantation Method Prospective observational study including 23 consecutively recruited patients at one single center. Patients with a previous history of surgical intervention on urinary tract before transplant were excluded. Pigtail stents were removed as for local protocol between 3 and 4 weeks after transplantation in aseptic condition and were cut in a half (proximal and distal) and analyzed separately. Stent colonization were detected by sonication method. Urine culture timing are depicted in Figure 1. In case of clinical symptoms, extra urine cultive were performed as for clinical practice. Patient were followed for 6 months, and results of stent colonization were blinded to clinicians. Results Table 1 shows main characteristic of our cohort. Conclusion


1990 ◽  
Vol 26 (5) ◽  
pp. 871
Author(s):  
Y Yoon ◽  
D W Sung ◽  
W S Choi ◽  
D H Lee ◽  
Y T Ko ◽  
...  

2021 ◽  
pp. 378-385
Author(s):  
Hitoshi Sugimoto ◽  
Goshi Oda ◽  
Minato Yokoyama ◽  
Kumiko Hayashi ◽  
Maho Yoshino ◽  
...  

Breast cancer metastasizes mainly to organs such as bone, lung, and liver, whereas metastases to the peritoneum and urinary tract are rare. Metastasis to the peritoneum or urinary tract may result in renal dysfunction, infection, and painful hydronephrosis. In our hospital, 1,409 breast cancer surgeries were performed between January 2004 and December 2015, and 7 cases of hydronephrosis associated with recurrence were observed. The median age of patients was 69 years (57–79 years). The median time from surgery to diagnosis of hydronephrosis was 47 months (20–70 months). Histology was invasive ductal carcinoma (IDC) in 6 cases and invasive lobular carcinoma (ILC) in 1 case. There were 6 bilateral cases and 1 unilateral case of hydronephrosis. The causes were retroperitoneal metastasis in 5 cases and lymph node metastasis in 2 cases. The hydronephrosis was untreated in 2 cases, and treated with a ureteral stent in 2 cases, nephrostomy in 1 case, and nephrostomy due to ureteral stent failure in 2 cases. The median survival from the onset of hydronephrosis was 12 months (3–57 months). Although the probability of hydronephrosis in breast cancer recurrence was not high, care must be taken to avoid renal dysfunction, infection, or pain, which may require treatment.


2021 ◽  
pp. 205141582110002
Author(s):  
Mohammad Ali Ghaed ◽  
Reza Rezaei ◽  
Amineh Shafeinia ◽  
Robab Maghsoudi

Objective: Double-J stent is a common tool used in urological procedures that is inserted for 2–6 weeks, but it may induce abdominal and flank pain, incontinence and irritative urinary symptoms. Alleviation of such symptoms would be useful to improve the patients’ quality of life. Accordingly, in this study, the efficacy of cystone versus tamsulosin in the treatment of double-J stent-related lower urinary tract symptoms was determined. Materials and methods: In this randomised clinical trial, 128 patients who required double-J stent insertion after transureteral lithotripsy during 2018–2019 were enrolled. They were randomly assigned to receive either cystone, tamsulosin, both, or placebo. The international prostate symptom score and visual analogue score data were recorded at baseline, after 2 and 4 weeks across the groups. Results: The international prostate symptom score and visual analogue score factors were statistically different across the case groups receiving cystone, tamsulosin and both drugs versus placebo ( P=0.001). Two weeks after drug administration, the visual analogue score and international prostate symptom score were not statistically different in the tamsulosin, cystone and dual therapy groups; however, after 4 weeks the cystone group had the lowest symptoms. Conclusion: Both tamsulosin and cystone are efficient drugs which would relieve stent-related lower urinary tract symptoms. The administration of cystone with or without tamsulosin for 4 weeks may have the best result in reducing the visual analogue score and international prostate symptom score. Level of evidence: Level I, 1b, therapeutic study, randomised controlled trial


Sign in / Sign up

Export Citation Format

Share Document